Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Subjects

Subjects :

Cardiovascular Diseases diagnosis
Cardiovascular Diseases epidemiology
Clinical Decision-Making
Comorbidity
Consensus
Drug Interactions
Dyslipidemias diagnosis
Dyslipidemias epidemiology
Evidence-Based Medicine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacokinetics
Polypharmacy
Risk Assessment
Risk Factors
Treatment Outcome
United States
American Heart Association
Cardiovascular Diseases drug therapy
Dyslipidemias drug therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects

Details

Language :

English

ISSN :

1524-4539

Volume :

134

Issue :

21

Database :

MEDLINE

Journal :

Circulation

Publication Type :

Academic Journal

Accession number :

27754879

Full Text :

https://doi.org/10.1161/CIR.0000000000000456